Neoplasms
|
0.050 |
GeneticVariation
|
group |
BEFREE |
The p36 region of chromosome one has been reported to have frequent loss of heterozygosity (LOH) in brain and central nervous system (CNS) tumors and epidemiological studies have shown an increased relative risk of BC and tumors of the CNS in PC families.
|
11536309 |
2001 |
Neoplasms
|
0.050 |
GeneticVariation
|
group |
BEFREE |
LOH at 1 p36 retained independent prognostic significance in a multivariate model that included KIT mutation status and tumor size; the mitotic index, however, did not retain independent significance in such a model.
|
10616197 |
1999 |
Brain Neoplasms
|
0.020 |
GeneticVariation
|
group |
BEFREE |
The p36 region of chromosome one has been reported to have frequent loss of heterozygosity (LOH) in brain and central nervous system (CNS) tumors and epidemiological studies have shown an increased relative risk of BC and tumors of the CNS in PC families.
|
11536309 |
2001 |
Malignant Neoplasms
|
0.020 |
GeneticVariation
|
group |
BEFREE |
Southern analysis of cancer DNA showed no noticeable deletion in p36 gene.
|
11522620 |
2001 |
Gerstmann-Straussler-Scheinker Disease
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Mutations in P36 and P46 lead to glycogen storage disease (GSD) type-1a and type-1 non a (formerly 1b and 1c), respectively.
|
10712583 |
2000 |
Glycogen Storage Disease
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Mutations in P36 and P46 lead to glycogen storage disease (GSD) type-1a and type-1 non a (formerly 1b and 1c), respectively.
|
10712583 |
2000 |
Massive Osteolyses
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Mutations in P36 and P46 lead to glycogen storage disease (GSD) type-1a and type-1 non a (formerly 1b and 1c), respectively.
|
10712583 |
2000 |
Central Nervous System Neoplasms
|
0.010 |
GeneticVariation
|
group |
BEFREE |
The p36 region of chromosome one has been reported to have frequent loss of heterozygosity (LOH) in brain and central nervous system (CNS) tumors and epidemiological studies have shown an increased relative risk of BC and tumors of the CNS in PC families.
|
11536309 |
2001 |
Malignant neoplasm of brain
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The p36 region of chromosome one has been reported to have frequent loss of heterozygosity (LOH) in brain and central nervous system (CNS) tumors and epidemiological studies have shown an increased relative risk of BC and tumors of the CNS in PC families.
|
11536309 |
2001 |
Malignant neoplasm of prostate
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The p36 region of chromosome one has been reported to have frequent loss of heterozygosity (LOH) in brain and central nervous system (CNS) tumors and epidemiological studies have shown an increased relative risk of BC and tumors of the CNS in PC families.
|
11536309 |
2001 |
Prostate carcinoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The p36 region of chromosome one has been reported to have frequent loss of heterozygosity (LOH) in brain and central nervous system (CNS) tumors and epidemiological studies have shown an increased relative risk of BC and tumors of the CNS in PC families.
|
11536309 |
2001 |
Primary malignant neoplasm
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Southern analysis of cancer DNA showed no noticeable deletion in p36 gene.
|
11522620 |
2001 |
Neoplasms
|
0.050 |
Biomarker
|
group |
BEFREE |
Loss of heterozygosity (LOH) involving the distal chromosome 1 p36 region occurs frequently in nonastrocytic brain tumours, but the tumour suppressor gene targeted by this deletion is unknown. p73 is a novel gene that has high sequence homology and similar gene structure to the p53 gene; it has been mapped to 1 p36, and may thus represent a candidate for this tumour suppressor gene.
|
11461077 |
2001 |
Neoplasms
|
0.050 |
Biomarker
|
group |
BEFREE |
The presence of 1p abnormalities in AML and other malignancies is reviewed, as are candidate tumor suppressor genes in the 1p34 approximately p36 region.
|
12547161 |
2002 |
Neoplasms
|
0.050 |
Biomarker
|
group |
BEFREE |
Cytogenetic and molecular studies in neuroblastoma suggest the presence of a tumor suppressor gene at the distal band p36 of human chromosome 1.
|
7700633 |
1995 |
Brain Neoplasms
|
0.020 |
Biomarker
|
group |
BEFREE |
Loss of heterozygosity (LOH) involving the distal chromosome 1 p36 region occurs frequently in nonastrocytic brain tumours, but the tumour suppressor gene targeted by this deletion is unknown. p73 is a novel gene that has high sequence homology and similar gene structure to the p53 gene; it has been mapped to 1 p36, and may thus represent a candidate for this tumour suppressor gene.
|
11461077 |
2001 |
Malignant Neoplasms
|
0.020 |
Biomarker
|
group |
BEFREE |
The presence of 1p abnormalities in AML and other malignancies is reviewed, as are candidate tumor suppressor genes in the 1p34 approximately p36 region.
|
12547161 |
2002 |
Crohn Disease
|
0.020 |
Biomarker
|
disease |
BEFREE |
The reactivity of anti-M. paratuberculosis (specifically against p35 and p36 antigens) antibodies in a significant proportion of CD patients would suggest a causal role for the organism in CD.
|
11118734 |
2000 |
Crohn Disease
|
0.020 |
Biomarker
|
disease |
BEFREE |
The fact that sera from Crohn's disease patients reacted to p36 with the same high frequency as the sera from patients that were exposed to mycobacterial antigens further supports the hypothesis of the mycobacterial etiology in Crohn's disease.
|
10398839 |
1999 |
Malaria
|
0.020 |
Biomarker
|
disease |
BEFREE |
A protein called P36 holds the key to how different species of malaria parasite invade liver cells.
|
28614050 |
2017 |
Neuroblastoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
LOH at 1p36 was found in 24 of 80 cases, suggesting the possibility of a tumor suppressor gene at 1 p36 near the site of a suspected neuroblastoma tumor suppressor gene.
|
10616197 |
1999 |
Neuroblastoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Cytogenetic and molecular studies in neuroblastoma suggest the presence of a tumor suppressor gene at the distal band p36 of human chromosome 1.
|
7700633 |
1995 |
Paratuberculosis
|
0.020 |
Biomarker
|
disease |
BEFREE |
Characterization of Mycobacterium paratuberculosis p36 antigen and its seroreactivities in Crohn's disease.
|
10398839 |
1999 |
Paratuberculosis
|
0.020 |
Biomarker
|
disease |
BEFREE |
Specific seroreactivity of Crohn's disease patients against p35 and p36 antigens of M. avium subsp. paratuberculosis.
|
11118734 |
2000 |
Central neuroblastoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
LOH at 1p36 was found in 24 of 80 cases, suggesting the possibility of a tumor suppressor gene at 1 p36 near the site of a suspected neuroblastoma tumor suppressor gene.
|
10616197 |
1999 |